AICDA, activation induced cytidine deaminase, 57379

N. diseases: 265; N. variants: 16
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 GeneticVariation disease BEFREE AID is mutated in hyper-IgM type 2 (HIGM2) syndrome. 28790320 2017
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 GeneticVariation disease UNIPROT Activation induced cytidine deaminase mutant (AID-His130Pro) from Hyper IgM 2 patient retained mutagenic activity on SHM artificial substrate. 27716525 2016
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 Biomarker disease GENOMICS_ENGLAND Decreased somatic hypermutation induces an impaired peripheral B cell tolerance checkpoint. 27701145 2016
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 GeneticVariation disease UNIPROT Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients. 26545377 2016
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 GeneticVariation disease UNIPROT To our knowledge, this is a new AICDA mutation found in HIGM2 patients. 23803409 2013
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 GeneticVariation disease BEFREE To our knowledge, this is a new AICDA mutation found in HIGM2 patients. 23803409 2013
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 GeneticVariation disease UNIPROT Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. 14962793 2004
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 GermlineCausalMutation disease ORPHANET The phenotype observed in HIGM2 patients (and in AID-/- mice) demonstrates the absolute requirement for AID in several crucial steps of B cell terminal differentiation necessary for efficient antibody responses. 11007475 2000
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 GeneticVariation disease UNIPROT The phenotype observed in HIGM2 patients (and in AID-/- mice) demonstrates the absolute requirement for AID in several crucial steps of B cell terminal differentiation necessary for efficient antibody responses. 11007475 2000
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 Biomarker disease BEFREE The phenotype observed in HIGM2 patients (and in AID-/- mice) demonstrates the absolute requirement for AID in several crucial steps of B cell terminal differentiation necessary for efficient antibody responses. 11007475 2000
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 GeneticVariation disease CLINVAR
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 Biomarker disease CTD_human
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 Biomarker disease GENOMICS_ENGLAND
Hyper-IgM Immunodeficiency Syndrome, Type 2
0.730 CausalMutation disease CLINVAR
CUI: C0272236
Disease: Hyperimmunoglobulin M syndrome
Hyperimmunoglobulin M syndrome
0.400 Biomarker disease BEFREE A 42-year-old man with hyper-IgM syndrome type 2 caused by activation-induced cytidine deaminase (AID) deficiency developed a severe anaphylactic reaction to intravenous immunoglobulin. 29255996 2018
CUI: C0272236
Disease: Hyperimmunoglobulin M syndrome
Hyperimmunoglobulin M syndrome
0.400 GeneticVariation disease BEFREE Enrichment of rare variants in population isolates: single AICDA mutation responsible for hyper-IgM syndrome type 2 in Finland. 27142677 2016
CUI: C0272236
Disease: Hyperimmunoglobulin M syndrome
Hyperimmunoglobulin M syndrome
0.400 Biomarker disease BEFREE Impaired immune functions leading to primary immunodeficiencies often correlate with paradoxical autoimmune complications; patients with hyper-IgM syndromes who are deficient in activation-induced cytidine deaminase (AID), which is required for class-switch recombination and somatic hypermutation, are prone to develop autoimmune diseases. 21700883 2011
CUI: C0272236
Disease: Hyperimmunoglobulin M syndrome
Hyperimmunoglobulin M syndrome
0.400 Biomarker disease BEFREE Defects in AID and UNG2 have been shown to result in the primary immunodeficiency hyper-IgM syndrome, leading us to hypothesize that additional, potentially more subtle, DNA repair gene variations may underlie the clinically related antibody deficiencies syndromes IgAD and CVID. 20805886 2010
CUI: C0272236
Disease: Hyperimmunoglobulin M syndrome
Hyperimmunoglobulin M syndrome
0.400 GeneticVariation disease BEFREE S43P mutant AID has been identified in a patient with hyper-IgM immunodeficiency syndrome. 19022738 2009
CUI: C0272236
Disease: Hyperimmunoglobulin M syndrome
Hyperimmunoglobulin M syndrome
0.400 GeneticVariation disease BEFREE Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. 19575287 2009
CUI: C0272236
Disease: Hyperimmunoglobulin M syndrome
Hyperimmunoglobulin M syndrome
0.400 GeneticVariation disease BEFREE A novel activation-induced cytidine deaminase gene mutation in a Tunisian family with hyper IgM syndrome. 15372234 2004
CUI: C0272236
Disease: Hyperimmunoglobulin M syndrome
Hyperimmunoglobulin M syndrome
0.400 GeneticVariation disease BEFREE The gene encoding activation-induced cytidine deaminase (AID) is responsible for the autosomal recessive form of hyper-IgM syndrome. 14564357 2003
CUI: C0272236
Disease: Hyperimmunoglobulin M syndrome
Hyperimmunoglobulin M syndrome
0.400 GeneticVariation disease BEFREE We herein report mutations in the human counterpart of AID in patients with the autosomal recessive form of hyper-IgM syndrome (HIGM2). 11007475 2000
CUI: C0272236
Disease: Hyperimmunoglobulin M syndrome
Hyperimmunoglobulin M syndrome
0.400 Biomarker disease BEFREE Lymphoid hyperplasia was seen in patients with hyper IgM syndrome and normal AID as well as the patients with hyper IgM syndrome and defects in AID. 11112359 2000
CUI: C0272236
Disease: Hyperimmunoglobulin M syndrome
Hyperimmunoglobulin M syndrome
0.400 Biomarker disease CTD_human